Genomic sequence reveals new treatment options for pancreatic cancer

February 27, 2015 7:44 AM

13 0

While many advances have been made in other types of cancer, pancreatic cancer remains largely incurable, with survival rates less than five per cent five years after diagnosis.

The Australian Pancreatic Genome Initiative (APGI), funded by the NHMRC and led by a team at the Garvan Institute and Kinghorn Cancer Centre in Sydney, has led an international program aimed at changing this.

Read more

To category page